hCAI/II/IV-IN-28

CAS No. 78659-11-7

hCAI/II/IV-IN-28( —— )

Catalog No. M37274 CAS No. 78659-11-7

hCAI/II/IV-IN-28(WAY-638358) is a potent carbonic anhydrase inhibitor with potential anticonvulsant activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 185 In Stock
10MG 271 In Stock
25MG 427 In Stock
50MG 559 In Stock
100MG 749 In Stock
200MG 1014 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    hCAI/II/IV-IN-28
  • Note
    Research use only, not for human use.
  • Brief Description
    hCAI/II/IV-IN-28(WAY-638358) is a potent carbonic anhydrase inhibitor with potential anticonvulsant activity.
  • Description
    hCAI/II/IV-IN-28(WAY-638358) is a potent carbonic anhydrase inhibitor with potential anticonvulsant activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Carbonic Anhydrase
  • Recptor
    Carbonic Anhydrase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    78659-11-7
  • Formula Weight
    305.35
  • Molecular Formula
    C14H15N3O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NCCC1=CC=C(C=C1)S(=O)(=O)N)C2=NC=CC=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • (Iso)-Samixogrel

    (Iso)-Samixogrel shows activity against Carbonic anhydrase and Cyclooxygenase 2.

  • Cinnamic acid

    Cinnamic acid exerts anti-diabetic activity by improving glucose tolerance in vivo and by stimulating insulin secretion in vitro.

  • Mafenide hydrochlori...

    Mafenide hydrochloride is a sulfonamide-type medication used as an antibiotic.